Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing daprodustat to darbepoetin alfa in Japanese hemodialysis patients with CKD-related anemia completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Daprodustat (daprodustat)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 3 | Status: COMPLETED | Results posted: 2019-11-29